Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Deloitte
Covington
Julphar
Healthtrust
Citi
Federal Trade Commission
Teva
Dow
Johnson and Johnson

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020825

« Back to Dashboard

NDA 020825 describes GEODON, which is a drug marketed by Pfizer and Pfizer Inc and is included in three NDAs. It is available from eleven suppliers. There are six patents protecting this drug and one Paragraph IV challenge. Additional details are available on the GEODON profile page.

The generic ingredient in GEODON is ziprasidone mesylate. There are twenty-one drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ziprasidone mesylate profile page.
Summary for 020825
Tradename:GEODON
Applicant:Pfizer
Ingredient:ziprasidone hydrochloride
Patents:2
Therapeutic Class:Antipsychotics
Bipolar Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 020825
Suppliers and Packaging for NDA: 020825
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825 NDA Roerig 0049-0052 0049-0052-80 80 BLISTER PACK in 1 CARTON (0049-0052-80) > 1 CAPSULE in 1 BLISTER PACK
GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825 NDA Roerig 0049-0052 0049-0052-60 60 CAPSULE in 1 BOTTLE (0049-0052-60)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 20MG BASE
Approval Date:Feb 5, 2001TE:ABRLD:Yes
Patent:➤ SubscribePatent Expiration:May 27, 2019Product Flag?YSubstance Flag?Delist Request?
Patent:➤ SubscribePatent Expiration:Dec 18, 2018Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF BIPOLAR DISORDER

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 40MG BASE
Approval Date:Feb 5, 2001TE:ABRLD:Yes
Patent:➤ SubscribePatent Expiration:May 27, 2019Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 020825

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-002 Feb 5, 2001 ➤ Subscribe ➤ Subscribe
Pfizer GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-001 Feb 5, 2001 ➤ Subscribe ➤ Subscribe
Pfizer GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-004 Feb 5, 2001 ➤ Subscribe ➤ Subscribe
Pfizer GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-004 Feb 5, 2001 ➤ Subscribe ➤ Subscribe
Pfizer GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-001 Feb 5, 2001 ➤ Subscribe ➤ Subscribe
Pfizer GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-002 Feb 5, 2001 ➤ Subscribe ➤ Subscribe
Pfizer GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-003 Feb 5, 2001 ➤ Subscribe ➤ Subscribe
Pfizer GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-003 Feb 5, 2001 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Express Scripts
McKesson
Fish and Richardson
Teva
Daiichi Sankyo
Julphar
Deloitte
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot